A detailed history of Smith Thornton Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Smith Thornton Advisors LLC holds 11,035 shares of PFE stock, worth $294,855. This represents 0.21% of its overall portfolio holdings.

Number of Shares
11,035
Previous 11,120 0.76%
Holding current value
$294,855
Previous $311 Million 2.64%
% of portfolio
0.21%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$27.7 - $31.39 $2,354 - $2,668
-85 Reduced 0.76%
11,035 $319 Million
Q2 2024

Aug 15, 2024

BUY
$25.26 - $29.6 $280,891 - $329,152
11,120 New
11,120 $311 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Smith Thornton Advisors LLC Portfolio

Follow Smith Thornton Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Thornton Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Thornton Advisors LLC with notifications on news.